semaglutide drug shortage list Shortages improve for Lilly's GLP-1 weight loss drugs, bumping sales forecast by $3bn FDA: Novo Nordisk's Ozempic and
Description
Read important safety and prescribing info on this page.
Novo Nordisk's Wegovy pill expands obesity drug market Novo Nordisk's oral GLP-1 treatment, the Wegovy pill, has seen high demand since its January launch, attracting patients who previously avoided injections due to needle fear or high costs
Obesity is a significant health concern, affecting millions and placing a heavy burden on healthcare systems
Payer contracting plays a key role in this market as brands compete for preferred formulary placement
